nocred
Researchers at the University of Pennsylvania School of Medicine and Immunocore Limited, Oxford, UK, today announced that a targeted agent that may have a role in treating advanced metastatic melanoma in the future has received Investigational New Drug (IND) approval and is opening enrollment for clinical trials in the UK and USA.
Click here to view the full release.
Karen Kreeger
nocred
nocred
Despite the commonality of water and ice, says Penn physicist Robert Carpick, their physical properties are remarkably unique.
(Image: mustafahacalaki via Getty Images)
Organizations like Penn’s Netter Center for Community Partnerships foster collaborations between Penn and public schools in the West Philadelphia community.
nocred